A Study to Test Whether BI 3034701 Helps People to Lose Weight Who Live With Obesity or Overweight
Public ClinicalTrials.gov record NCT07662122. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Randomised, Double-blind, Parallel-group, 42-week Dose-finding Trial for BI 3034701 Administered Subcutaneously Compared to Placebo in Participants With Obesity or Overweight
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is open to adults between 18 and 74 years of age and who have a body mass index (BMI) of 30 kg/m2 or more, or a BMI of 27 kg/m2 or more and at least 1 health problem related to their weight. People who have previously not managed to lose weight by changing their diet can participate. People with type 2 diabetes cannot take part in this study. The purpose of this study is to find out whether a medicine called BI 3034701 helps people living with obesity or overweight to lose weight. This study has 7 groups of participants. Groups 1 to 6 get different doses of BI 3034701; Group 7 gets placebo. Placebo looks like BI 3034701 but does not contain any medicine. Every participant has more than an 80% chance of getting BI 3034701. Participants receive 2 injections of BI 3034701 or placebo under their skin for 42 weeks. In addition to the study medicine, all participants receive counselling to make changes to their diet and to exercise regularly. Participants are in the study for about 10 months. During this time, they visit the study site 15 times. The study doctors regularly measure the participants' body weight and take necessary laboratory tests. Participants also answer questions about their well-being and note their food intake and physical activity in diaries. The results will be compared between groups of participants to see whether the treatment works. The study doctors also regularly check participants' health and take note of any unwanted effects.
Study identification
- NCT ID
- NCT07662122
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 344 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 74 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2026 (Actual)
- Primary completion
- Jun 26, 2027 (Estimated)
- Completion
- Jul 10, 2027 (Estimated)
- Last update posted
- Oct 13, 2026
2026 – 2027
United States locations
- U.S. sites
- 19
- U.S. states
- 13
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cahaba Research, Inc. - Trussville Location | Birmingham | Alabama | 35235 | — |
| Focus Clinical Research | West Hills | California | 91307 | — |
| Optimus U Corporation-Miami-69452 | Miami | Florida | 33135 | — |
| Javara-Fayetteville-67354 | Fayetteville | Georgia | 30214 | — |
| Monroe Biomedical Research - Louisville | Louisville | Kentucky | 40213 | — |
| Arcturus Healthcare - Troy Internal Medicine Research Division | Troy | Michigan | 48098 | — |
| StudyMetrix Research, LLC | City of Saint Peters | Missouri | 63303 | — |
| Clinvest Research LLC | Springfield | Missouri | 65807 | — |
| Centricity Research - Morehead City | Morehead City | North Carolina | 28557 | — |
| Accellacare-Wilmington-67123 | Wilmington | North Carolina | 28401 | — |
| Lillestol Research, LLC | Fargo | North Dakota | 58104 | — |
| Tribe Clinical Research at Parkside OB-GYN, Greer | Greer | South Carolina | 29650 | — |
| Texas Diabetes and Endocrinology - Central Austin | Austin | Texas | 78731 | — |
| South Texas Research Institute - Brownsville | Brownsville | Texas | 78520 | — |
| South Texas Research Institute-Edinburg-67012 | Edinburg | Texas | 78539 | — |
| IMA Clinical Research San Antonio | San Antonio | Texas | 78229 | — |
| Data Point Clinical, LLC | Kirkland | Washington | 98034 | — |
| Rainier Clinical Research Center | Renton | Washington | 98057 | — |
| Allegiance Research Specialists | Wauwatosa | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 35 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07662122, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 13, 2026 · Synced Oct 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07662122 live on ClinicalTrials.gov.